Roberta Carbonara

Preclinical evaluation of marketed sodium channel blockers in a rat model of myotonia discloses promising antimyotonic drugs

Jean‐François Desaphy, Roberta Carbonara, Teresa Costanza et al. · Experimental Neurology · 2014 · 54 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Radiomic analysis to predict local response in locally advanced pancreatic cancer treated with stereotactic body radiation therapy

Fabiana Gregucci, Alba Fiorentino, Rosario Mazzola et al. · La radiologia medica · 2021 · 38 citations

Medicine, Oncology, Radiation Oncology +17

Increased sodium channel use-dependent inhibition by a new potent analogue of tocainide greatly enhances in vivo antimyotonic activity

Michela De Bellis, Roberta Carbonara, Julien Roussel et al. · Neuropharmacology · 2016 · 33 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12

Synthesis and Toxicopharmacological Evaluation of<i>m</i>-Hydroxymexiletine, the First Metabolite of Mexiletine More Potent Than the Parent Compound on Voltage-Gated Sodium Channels

Alessia Catalano, Jean‐François Desaphy, Giovanni Lentini et al. · Journal of Medicinal Chemistry · 2011 · 28 citations · Full text

Pharmacy, Pharmacology, Toxicology +12

Combined Modifications of Mexiletine Pharmacophores for New Lead Blockers of Nav1.4 Channels

Michela De Bellis, Annamaria De Luca, Jean‐François Desaphy et al. · Biophysical Journal · 2013 · 28 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17